arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2211.14149eess.SYcs.SY
收藏

根据2型糖尿病患者的短期闭环数据估计个性化基础胰岛素剂量

Estimating a Personalized Basal Insulin Dose from Short-Term Closed-Loop Data in Type 2 Diabetes

Sarah Ellinor Engell, Tinna Björk Aradóttir, Tobias K. S. Ritschel, Henrik Bengtsson, John Bagterp Jørgensen

摘要:

在2型糖尿病(T2 D)治疗中,寻找安全有效的基础胰岛素剂量是一项挑战。剂量反应是高度个体化的,为了确保安全性,T2 D患者通过缓慢增加每日胰岛素剂量来滴定,以达到治疗目标。这种滴定可能需要数月时间。为了缓解和加速这一过程,我们使用为初始滴定量身定制的短期人工胰腺(AP)治疗,并将其用作诊断工具。具体来说,我们提出了一种方法来自动估计从AP收集的闭环数据的基础胰岛素的个性化的每日剂量。基于随机模拟模型的AP数据,我们采用连续-离散扩展卡尔曼滤波器和最大似然方法来估计100个虚拟人的简单剂量反应模型中的参数。通过确定的模型,我们计算基础胰岛素的每日剂量,以满足每个人的治疗目标。我们测试了个性化剂量,并根据临床参考值评估了治疗结果。在测试的仿真装置中,所提出的方法是可行的。然而,更广泛的测试将揭示它是否可以被认为是安全的临床实施。

英文摘要:

In type 2 diabetes (T2D) treatment, finding a safe and effective basal insulin dose is a challenge. The dose-response is highly individual and to ensure safety, people with T2D titrate by slowly increasing the daily insulin dose to meet treatment targets. This titration can take months. To ease and accelerate the process, we use short-term artificial pancreas (AP) treatment tailored for initial titration and apply it as a diagnostic tool. Specifically, we present a method to automatically estimate a personalized daily dose of basal insulin from closed-loop data collected with an AP. Based on AP-data from a stochastic simulation model, we employ the continuous-discrete extended Kalman filter and a maximum likelihood approach to estimate parameters in a simple dose-response model for 100 virtual people. With the identified model, we compute a daily dose of basal insulin to meet treatment targets for each individual. We test the personalized dose and evaluate the treatment outcomes against clinical reference values. In the tested simulation setup, the proposed method is feasible. However, more extensive tests will reveal whether it can be deemed safe for clinical implementation.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑